Epigenetic Modulation of the immunE Response in GastrointEstinal Cancers (EMERGE)
Clinical trial NCT03812796 · UNKNOWN
Trial details
- NCT number
- NCT03812796
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-11
- Primary completion
- 2021-11-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.